{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:45:16Z","timestamp":1792507516287,"version":"4.5.0"},"reference-count":96,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,12,28]],"date-time":"2009-12-28T00:00:00Z","timestamp":1261958400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1002\/art.25061","type":"journal-article","created":{"date-parts":[[2009,12,28]],"date-time":"2009-12-28T21:07:02Z","timestamp":1262034422000},"page":"9-21","source":"Crossref","is-referenced-by-count":183,"title":["Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: A data\u2010driven review"],"prefix":"10.1002","volume":"62","author":[{"given":"Paul A.","family":"Monach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay M.","family":"Arnold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A.","family":"Merkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,12,28]]},"reference":[{"key":"e_1_2_14_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198603063141004"},{"key":"e_1_2_14_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197908023010503"},{"key":"e_1_2_14_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-125-7-199610010-00003"},{"key":"e_1_2_14_5_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa055120"},{"key":"e_1_2_14_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.088096"},{"key":"e_1_2_14_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043731"},{"key":"e_1_2_14_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa041884"},{"key":"e_1_2_14_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22204"},{"key":"e_1_2_14_10_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007010090"},{"key":"e_1_2_14_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198804213181604"},{"key":"e_1_2_14_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0305-7372(85)90011-8"},{"key":"e_1_2_14_13_2","unstructured":"StoneJH. General principles of the use of cyclophosphamide in rheumatic and renal diseases. UpToDate online2008; version 16.3. Online athttp:\/\/uptodateonline.com."},{"key":"e_1_2_14_14_2","first-page":"1405","volume-title":"Rheumatology","author":"Boumpas DT","year":"2003"},{"key":"e_1_2_14_15_2","first-page":"1561","volume-title":"Arthritis and allied conditions: a textbook of rheumatology","author":"Wofsy D","year":"2005"},{"key":"e_1_2_14_16_2","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.7-5-393"},{"key":"e_1_2_14_17_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.10.3333"},{"key":"e_1_2_14_18_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199834010-00004"},{"key":"e_1_2_14_19_2","first-page":"319","volume-title":"Cancer chemotherapy handbook","author":"Dorr RT","year":"1994"},{"key":"e_1_2_14_20_2","first-page":"301","article-title":"Comparative pharmacologic study in vitro and in vivo with cyclophosphamide (NSC\u201026271), cyclophosphamide metabolites, and plain nitrogen mustard compounds","volume":"60","author":"Brock N","year":"1976","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_14_21_2","first-page":"659","article-title":"Acrolein, the causative factor of urotoxic side\u2010effects of cyclophosphamide, ifosfamide, trofosfamide and sufosfamide","volume":"29","author":"Brock N","year":"1979","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_14_22_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2006001100011"},{"key":"e_1_2_14_23_2","first-page":"1049","article-title":"Carcinosarcoma of bladder following long\u2010term cyclophosphamide therapy","volume":"115","author":"Sigal SH","year":"1991","journal-title":"Arch Pathol Lab Med"},{"key":"e_1_2_14_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)36156-6"},{"key":"e_1_2_14_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-198004000-00011"},{"key":"e_1_2_14_26_2","first-page":"2723","article-title":"Plasma pharmacokinetics of cyclophosphamide and its cytotoxic metabolites after intravenous versus oral administration in a randomized, crossover trial","volume":"47","author":"Struck RF","year":"1987","journal-title":"Cancer Res"},{"key":"e_1_2_14_27_2","volume-title":"Cytoxan prescribing information","year":"2005"},{"key":"e_1_2_14_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa020286"},{"key":"e_1_2_14_29_2","first-page":"195","article-title":"Randomised controlled trial of daily oral versus pulse cyclophosphamide for induction of remission in ANCA\u2010associated systemic vasculitis","volume":"28","author":"De Groot K","year":"2005","journal-title":"Kidney Blood Press Res"},{"key":"e_1_2_14_30_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-135-4-200108210-00009"},{"key":"e_1_2_14_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.070367"},{"key":"e_1_2_14_32_2","first-page":"838","article-title":"Cyclophosphamide and low\u2010dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease","volume":"20","author":"Silver RM","year":"1993","journal-title":"J Rheumatol"},{"key":"e_1_2_14_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310402"},{"key":"e_1_2_14_34_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-124-5-199603010-00003"},{"key":"e_1_2_14_35_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200005)43:5<1021::AID-ANR10>3.0.CO;2-J"},{"key":"e_1_2_14_36_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-91-2-221"},{"key":"e_1_2_14_37_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-99-1-1"},{"key":"e_1_2_14_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780160405"},{"key":"e_1_2_14_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380815"},{"key":"e_1_2_14_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780190308"},{"key":"e_1_2_14_41_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V95842"},{"key":"e_1_2_14_42_2","first-page":"100","article-title":"Malignancies in Wegener's granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients","volume":"35","author":"Faurschou M","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_14_43_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.019125"},{"key":"e_1_2_14_44_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.10444"},{"key":"e_1_2_14_45_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.7.524"},{"key":"e_1_2_14_46_2","unstructured":"Cancer statistics cancer fact sheets urinary bladder. Surveillance Epidemiology and End Results (SEER) online2008.http:\/\/seer.cancer.gov\/statfacts\/html\/urinb."},{"key":"e_1_2_14_47_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-003-0382-8"},{"key":"e_1_2_14_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/16.10.2018"},{"key":"e_1_2_14_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(90)90367-M"},{"key":"e_1_2_14_50_2","doi-asserted-by":"publisher","DOI":"10.1080\/03009740701687234"},{"key":"e_1_2_14_51_2","doi-asserted-by":"publisher","DOI":"10.1177\/096120339700600307"},{"key":"e_1_2_14_52_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/37.6.659"},{"key":"e_1_2_14_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199810)41:10<1835::AID-ART16>3.0.CO;2-Q"},{"key":"e_1_2_14_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401213"},{"key":"e_1_2_14_55_2","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/90.6.401"},{"key":"e_1_2_14_56_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.56.8.481"},{"key":"e_1_2_14_57_2","doi-asserted-by":"publisher","DOI":"10.1159\/000186790"},{"key":"e_1_2_14_58_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1445-5994.2002.d01-29.x"},{"key":"e_1_2_14_59_2","first-page":"133","article-title":"Bladder cancer in a young girl with systemic lupus erythematosus treated with cyclophosphamide","volume":"59","author":"Alivizatos G","year":"1991","journal-title":"Acta Urol Belg"},{"key":"e_1_2_14_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.21029"},{"key":"e_1_2_14_61_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1422.008"},{"key":"e_1_2_14_62_2","doi-asserted-by":"publisher","DOI":"10.1191\/0961203303lu443oa"},{"key":"e_1_2_14_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/39.10.1147"},{"key":"e_1_2_14_64_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390625"},{"key":"e_1_2_14_65_2","first-page":"1478","article-title":"Risk of malignancy in women with systemic lupus erythematosus","volume":"22","author":"Sweeney DM","year":"1995","journal-title":"J Rheumatol"},{"key":"e_1_2_14_66_2","doi-asserted-by":"publisher","DOI":"10.1191\/096120301678416079"},{"key":"e_1_2_14_67_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199142030-00006"},{"key":"e_1_2_14_68_2","first-page":"685","volume-title":"Cancer chemotherapy handbook","author":"Dorr RT","year":"1994"},{"issue":"1","key":"e_1_2_14_69_2","first-page":"48","article-title":"Chemoprotectants for cancer chemotherapy","volume":"18","author":"Dorr RT","year":"1991","journal-title":"Semin Oncol"},{"key":"e_1_2_14_70_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00180290"},{"key":"e_1_2_14_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)49751-5"},{"key":"e_1_2_14_72_2","doi-asserted-by":"publisher","DOI":"10.1159\/000281847"},{"key":"e_1_2_14_73_2","first-page":"792","article-title":"Influence of sulfur\u2010containing compounds on the acute toxicity of cyclophosphamide in male Sprague\u2010Dawley rats","volume":"34","author":"Habs M","year":"1984","journal-title":"Arzneimittelforschung"},{"key":"e_1_2_14_74_2","first-page":"339","article-title":"The prevention of cyclophosphamide\u2010induced bladder swelling in the rat by I.V. administration of sodium\u20102\u2010mercaptoethane sulfonate","volume":"29","author":"Kedar A","year":"1980","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"e_1_2_14_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3835(86)90032-7"},{"key":"e_1_2_14_76_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200012)43:12<2853::AID-ANR30>3.0.CO;2-G"},{"key":"e_1_2_14_77_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1984.252"},{"key":"e_1_2_14_78_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.11.2016"},{"key":"e_1_2_14_79_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.7.1306"},{"key":"e_1_2_14_80_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.jjco.a039132"},{"key":"e_1_2_14_81_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01612769"},{"key":"e_1_2_14_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)92703-8"},{"key":"e_1_2_14_83_2","first-page":"501","article-title":"Controlled clinical studies with an antidote against the urotoxicity of oxazaphosphorines: preliminary results","volume":"63","author":"Scheef W","year":"1979","journal-title":"Cancer Treat Rep"},{"issue":"16","key":"e_1_2_14_84_2","first-page":"5829","article-title":"Crossover randomized comparison of intravenous versus intravenous\/oral mesna in soft tissue sarcoma treated with high\u2010dose ifosfamide","volume":"9","author":"Mace JR","year":"2003","journal-title":"Clin Cancer Res"},{"key":"e_1_2_14_85_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(83)80013-9"},{"key":"e_1_2_14_86_2","first-page":"1124","article-title":"Ifosfamide\/mesna and hematuria","volume":"71","author":"Pratt CB","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_14_87_2","first-page":"499","article-title":"Phase II trial of ifosfamide with mesna in previously treated metastatic sarcoma","volume":"69","author":"Antman KH","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_14_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(83)80018-8"},{"key":"e_1_2_14_89_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00254247"},{"key":"e_1_2_14_90_2","first-page":"663","article-title":"Phase II trial of ifosfamide and mesna in advanced colorectal cancer","volume":"71","author":"Kemeny N","year":"1987","journal-title":"Cancer Treat Rep"},{"key":"e_1_2_14_91_2","first-page":"21","volume-title":"Contributions to oncology","author":"Scheef W","year":"1980"},{"key":"e_1_2_14_92_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-006-0307-5"},{"issue":"6","key":"e_1_2_14_93_2","first-page":"43","article-title":"Current studies of ifosfamide for pediatric solid tumors and leukemia in the United States","volume":"19","author":"Pratt CB","year":"1992","journal-title":"Semin Oncol"},{"key":"e_1_2_14_94_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19830215)51:4<606::AID-CNCR2820510409>3.0.CO;2-S"},{"key":"e_1_2_14_95_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.04.178"},{"key":"e_1_2_14_96_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem146a"},{"key":"e_1_2_14_97_2","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199909)42:9<1785::AID-ANR1>3.0.CO;2-#"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.25061","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.25061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T15:14:04Z","timestamp":1700752444000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.25061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,28]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1002\/art.25061"],"URL":"https:\/\/doi.org\/10.1002\/art.25061","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,28]]}}}